Copy
October 08, 2019
Giving healthcare companies the exposure they deserve. Every Tuesday.
BioTuesdays by Kilmer Lucas
Share
Tweet
Share
Forward

FEATURED STORY

OncoSec TAVO technology aiming to reverse checkpoint inhibitor resistance

OncoSec Medical (NASDAQ:ONCS) is developing its TAVO drug candidate to enhance local delivery and uptake of DNA-based interleukin-12 (IL-12) directly into solid tumors to reverse patients’ resistance to checkpoint inhibitors.

“As successful as checkpoint inhibitors are, anywhere from 60% to 90% of patients with solid tumors don’t respond to drugs such as Merck’s KEYTRUDA,” Daniel O’Connor, president and CEO, says in an interview with BioTuesdays. 

Checkpoint inhibitors are a widely used form of cancer immunotherapy that stimulate the body’s own immune response. Some cancer cells make high levels of proteins that can halt the immune system, disrupting the ability of T-cells to attack cancer cells. Checkpoint inhibitors turn the immune system back on so T-cells are able to recognize and kill cancer cells.
Read the Story

SELECT BRIEFS

NASDAQ:BYSI

BeyondSpring

Presents novel NSCLC study design for plinabulin
 

NASDAQ:HEPA

Hepion Pharmaceuticals

Promotes Daren Ure, Daniel Trepanier and Patrick Mayo to management team
 

 

LumiThera

Enrolls first patient in U.S. multi-center trial in dry AMD
 

NASDAQ:RARX

Ra Pharmaceuticals

Doses first patient in pivotal Phase 3 myasthenia gravis study
 

More Briefs


Executive Moves


Markets


About BioTuesdays

 
BioTuesdays was created in 2009 by Kilmer Lucas, a leading healthcare-only investor relations firm. Employing a unique "outsourced in-house" partnership model, Kilmer Lucas designs and executes customized IR & PR programs for its drug development, medical device, cell therapy, diagnostics and healthcare services clients. But, most of BioTuesdays' content isn't client-driven. Rather, our mission is to give as many great healthcare companies and their stories as much exposure as we can.
Want to be featured in BioTuesdays? Get in touch with us.
Copyright © 2019 Kilmer Lucas, All rights reserved.
You are receiving this email because you signed up for the BioTuesdays newsletter.
Privacy Policy

BioTuesdays
PO Box 297
Carlisle, ON L0R 1H0 

subscribe | unsubscribe | update your preferences